Bliss GVS Pharma Ltd.

₹161.5

+ 6.60 (4.26%)

04:01 pm - close price

BSE: BLISSGVS

NSE: BLISSGVS

Industry: Pharmaceuticals & Drugs

House: Private

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 8.00Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.00Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.29Good: 20

🟡

Current Ratio

Bad: 1Current: 4.77Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.01Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 5.46Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 8.00Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.00Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.29Good: 20

🟡

Current Ratio

Bad: 1Current: 4.77Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.01Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 5.46Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	159.52	211.88	200.72	198.13	183.64
Expenditure+	135.31	157.51	157.02	169.78	149.31
Other Income+	5.11	12.60	5.42	5.60	4.12
Operating Profit	24.21	54.37	43.69	28.35	34.33
Interest	1.49	1.45	2.12	1.85	1.53
Depreciation and Amortization	6.19	6.39	6.95	6.85	6.85
Profit Before Tax	21.64	59.13	40.05	-3.95	30.07
Tax+	7.27	16.09	10.97	0.97	7.97
Net Profit	14.37	43.04	29.07	-4.91	22.11

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	57720.54	74745.41	75158.75	77024.49	80972.62
Operational Expenses+	47055.94	62911.33	63426.50	61962.23	68304.29
Operating Profit	10664.60	11834.08	11732.25	15062.26	12668.33
Other Income	2195.33	3149.19	1778.64	2873.74	3649.35
OPM %	18.48	15.83	15.61	19.56	15.65
Depreciation and Amortisation	1722.97	1733.08	1867.33	2637.98	2941.76
Interest	724.26	474.21	1036.40	691.21	812.00
Profit Before Tax	10412.70	5416.53	10607.16	11687.20	12563.92
Tax	2727.58	3439.26	2924.55	3443.43	3613.55
Net Profit	6849.09	1504.02	7085.88	7545.41	8429.93

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	107678.58	110874.66	115351.99	121158.85	130083.89
Liabilities+	107678.58	110874.66	115351.99	121158.85	130083.89

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	6396.94	13548.06	3431.35	10281.66	10591.29
Cash from Investing Activity	-4699.10	-9297.51	-775.09	-8318.98	-7544.09
Cash from Financing Activity	-2079.80	-2373.01	-2493.85	-2089.30	-3034.46
Net Cash Flow	-381.96	1877.54	162.41	-126.62	12.74
Opening Cash & Cash Equivalents	1533.95	1313.45	2198.71	2500.69	2359.06
Closing Cash & Cash Equivalents	1313.45	2198.71	2500.69	2359.06	2381.67

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	35.36	35.39	35.44	35.29	35.10	34.82	34.90	34.97	34.97	35.06
Public+	64.64	64.61	64.56	64.71	64.90	65.18	65.10	65.03	65.03	64.94
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	43380	44461	46707	49517	49558	52937	44737	45157	40758	43234

Profit & Loss

In Rs. Cr.	202103	202203	202303	202403	202503
Sales	57720.54	74745.41	75158.75	77024.49	80972.62
Operational Expenses+	47055.94	62911.33	63426.50	61962.23	68304.29
Operating Profit	10664.60	11834.08	11732.25	15062.26	12668.33
Other Income	2195.33	3149.19	1778.64	2873.74	3649.35
OPM %	18.48	15.83	15.61	19.56	15.65
Depreciation and Amortisation	1722.97	1733.08	1867.33	2637.98	2941.76
Interest	724.26	474.21	1036.40	691.21	812.00
Profit Before Tax	10412.70	5416.53	10607.16	11687.20	12563.92
Tax	2727.58	3439.26	2924.55	3443.43	3613.55
Net Profit	6849.09	1504.02	7085.88	7545.41	8429.93

Ratios

Reported EPS

Bad: 2Current: 8.00Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.00Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.29Good: 20

🟡

Current Ratio

Bad: 1Current: 4.77Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.01Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 5.46Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 8.00Good: 5

✅

Adjusted EPS

Bad: 3Current: 8.00Good: 6

✅

Return On Capital Employed (ROCE)

Bad: 10Current: 12.29Good: 20

🟡

Current Ratio

Bad: 1Current: 4.77Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.01Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 5.46Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Cash Flow Statement

In Rs. Cr.	202103	202203	202303	202403	202503
Cash from Operating Activity+	6396.94	13548.06	3431.35	10281.66	10591.29
Cash from Investing Activity	-4699.10	-9297.51	-775.09	-8318.98	-7544.09
Cash from Financing Activity	-2079.80	-2373.01	-2493.85	-2089.30	-3034.46
Net Cash Flow	-381.96	1877.54	162.41	-126.62	12.74
Opening Cash & Cash Equivalents	1533.95	1313.45	2198.71	2500.69	2359.06
Closing Cash & Cash Equivalents	1313.45	2198.71	2500.69	2359.06	2381.67

Quarterly Results

In Rs. Cr.	2023-06	2023-09	2023-12	2024-03	2024-06
Net Sales	159.52	211.88	200.72	198.13	183.64
Expenditure+	135.31	157.51	157.02	169.78	149.31
Other Income+	5.11	12.60	5.42	5.60	4.12
Operating Profit	24.21	54.37	43.69	28.35	34.33
Interest	1.49	1.45	2.12	1.85	1.53
Depreciation and Amortization	6.19	6.39	6.95	6.85	6.85
Profit Before Tax	21.64	59.13	40.05	-3.95	30.07
Tax+	7.27	16.09	10.97	0.97	7.97
Net Profit	14.37	43.04	29.07	-4.91	22.11

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Shareholder Pattern

In %	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24	DEC'23	SEP'23
Promoters+	35.36	35.39	35.44	35.29	35.10	34.82	34.90	34.97	34.97	35.06
Public+	64.64	64.61	64.56	64.71	64.90	65.18	65.10	65.03	65.03	64.94
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	43380	44461	46707	49517	49558	52937	44737	45157	40758	43234

Balance Sheet

In Rs. Cr.	202103	202203	202303	202403	202503
Assets+	107678.58	110874.66	115351.99	121158.85	130083.89
Liabilities+	107678.58	110874.66	115351.99	121158.85	130083.89

Peer Comparison

Consolidated

company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.99	16.16	26.60	20.88	45.55	45.55	16.00	2.89	2.33	0.03	60.44	0.62	38.10	30.72	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.02	15.35	31.03	23.29	82.68	82.68	30.00	4.84	3.40	0.00	973.00	0.56	69.83	59.00	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	15.36	18.34	18.58	14.29	65.29	65.29	16.00	4.24	3.21	0.00	111.00	1.08	22.08	18.20	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	13.23	26.46	17.36	11.34	56.47	56.47	32.00	1.19	0.66	0.40	11.59	1.17	57.28	40.45	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	14.77	21.08	13.61	10.10	44.99	44.99	11.00	1.89	1.45	0.13	32.55	1.46	19.69	16.11	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	13.41	18.61	24.39	17.54	67.81	67.81	8.00	1.92	1.37	0.14	28.15	0.76	16.87	12.84	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	12.63	21.13	11.59	8.89	71.87	71.87	12.00	1.87	1.26	0.30	14.62	1.42	28.20	20.67	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	10.15	16.98	23.25	15.83	48.25	48.25	0	1.23	0.86	0.58	6.83	0.64	50.22	38.05	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	7.54	11.15	8.69	5.48	60.02	60.02	0	1.85	1.13	0.24	12.08	1.38	19.32	13.12	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	14.77	19.93	13.72	11.48	181.14	181.14	45.00	2.73	1.99	0.09	21.76	1.29	26.94	22.67	6.85	26.10	0.64

Scroll horizontally to see more columns

Bliss GVS Pharma Ltd.

₹161.5

+ 6.60 (4.26%)

04:01 pm - close price

BSE: BLISSGVS

NSE: BLISSGVS

Industry: Pharmaceuticals & Drugs

House: Private

Overview